CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 1, Phase 2]

Phase 1/2a trial assessing safety and efficacy of ALY688 ophthalmic solution for dry eye disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Allysta Pharmaceutical | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-22